Akanda Corp.
Last updated September 27, 2026
Organization details
- Legal name
- Akanda Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2833 — Medicinal Chemicals & Botanical Products
- Jurisdiction of incorporation
- Ontario, Canada
- Headquarters city
- New Romney
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- AKAN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001888014
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $40,650
- 1 purchase by 1 insider
- Sold, last 12 months
- $10,150
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −7,868 | $1.29 | $10,150 |
| Jan 15, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +29,036 | $1.40 | $40,650 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Akari Therapeutics plc
Nasdaq: AKTX · Tampa, United Kingdom
Organization
AstraZeneca PLC
NYSE: AZN · Cambridge, United Kingdom
Organization
Autolus Therapeutics plc American Depositary Share
Nasdaq: AUTL · London, United Kingdom
Organization
Bicycle Therapeutics plc
Nasdaq: BCYC · Cambridge, United Kingdom
Organization
Questions about Akanda Corp.
Are Akanda Corp. insiders buying or selling shares?
Over the last 12 months, Akanda Corp. insiders bought $40,650 of shares in 1 purchase and sold $10,150 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="akanda-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.